Therefore, the mechanisms of USP5 deubiquitination and STAT3 ubiquitination in CRC remain a gap, and making progress in these areas will contribute to the prevention and treatment of CRC, potentially shedding light on the mechanism of action of α-hederin. The gene discussed is STAT3; the disease is colorectal carcinoma.